Financial performance and strategic moves shaping the sporting goods industry—covering earnings analysis, M&A and deals, capital markets activity, governance changes, and the macroeconomic forces driving profitability, valuations, and competitive positioning.
Behind the Enhanced Games’ NYSE debut: athletic bloodwork as raw material for consumer drug protocols sold via telehealth.
The news, analysis and competitive signals that matter — curated for industry professionals.
Sign up for freeU.S. Polo Assn. hits a record in worldwide retail sales and eyes $4 billion long term
Japan’s top sportswear maker posts its best-ever Q1, then watches its stock drop 6% as investors punish unchanged guidance.
The Japanese sporting goods manufacturer ended its 120th anniversary year with records across net sales, operating profit and net income.
On grows Q1 sales 26 percent as it builds toward scalable premium brand status — beyond its running roots.
Behind the Enhanced Games’ NYSE debut: athletic bloodwork as raw material for consumer drug protocols sold via telehealth.
Manchester sportswear brand targets £300m in revenue while its parent company reported rising sales and widening losses.
New data show Nike lost 3 points of global footwear share in 2025 – a third straight decline – as bearish bets on the stock hit a multi-year high.
From a French health insurtech to a sailing team and a Ligue 2 club, the Real Madrid forward is operating as a full-fledged investor.
Public sporting goods companies lost $67bn in aggregate market value in 2025 as tariff fears and operating challenges sent valuations down 14.3% on a weighted basis.
Which of the top 85 sporting goods companies performed best, and which lost ground in 2024? Get the figures.
Record activism in 2025 forced leadership changes at Lululemon, Nike, YETI and Under Armour as sophisticated funds exploited post-pandemic valuation gaps.